Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yu Shen

20PUBLICATIONS
68CO-AUTHORS
Midwifery not elsewhere classifiedPredictive and prognostic markersStochastic analysis and modellingCancer therapy (excl. chemotherapy and radiation therapy)European history (excl. British, classical Greek and Roman)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

Sort by Publication Date:
|Jan 28, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer.

Akshara Singareeka Raghavendra, Diane D Liu, Senthil Damodaran

|Oct 18, 2025
Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer.

Takeo Fujii, Toshiaki Iwase, Yu Shen

|May 26, 2025
Conformal predictive intervals in survival analysis: a resampling approach.

Jing Qin, Jin Piao, Jing Ning

|Feb 22, 2025
Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer.

Nina Tamirisa, Wenli Dong, Yu Shen

|Jan 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.

Akshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski

|Oct 29, 2024
Likelihood adaptively incorporated external aggregate information with uncertainty for survival data.

Ziqi Chen, Yu Shen, Jing Qin

Pageof 4

Frequent Collaborators

5 joint publications

Naoto T Ueno

4 joint publications

Debu Tripathy

3 joint publications

Isabelle Bedrosian

3 joint publications

Jing Ning

2 joint publications

Bora Lim

2 joint publications

Savitri Krishnamurthy

2 joint publications

Toshiaki Iwase

2 joint publications

Diane Liu

2 joint publications

Evan N Cohen

2 joint publications

Guadalupe Gómez Melis

Frequent Collaborators

5 joint publications

Naoto T Ueno

4 joint publications

Debu Tripathy

3 joint publications

Isabelle Bedrosian

3 joint publications

Jing Ning

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

13.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

11.0K
See more related videos

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

13.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

11.0K
See more related videos